Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2021

Feb 17, 2021

29821_dirs_2021-02-17_a07e8505-074e-4961-bad0-38bdd4e2bab0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-02-15

Reporting Person: Eddy Jodi Euerle (SVP, Chief Info & Digital Off.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-15 Common Stock M 923.0000 $0.0000 Acquired 17391.0000 Direct
2021-02-15 Common Stock F 271.0000 $38.3900 Disposed 17120.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-15 Deferred Stock Units $ M 923.0000 Disposed 2023-02-15 Common Stock (923.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Ms. Eddy's holdings exclude 2 shares of common stock which were previously mistakenly reported in her holdings due to an administrative error.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.